(Q39779533)

English

Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity

scientific article

Statements

Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity (English)
Phillip C C Liu
Mary Becker-Pasha
Gregory Hollis
Richard B Sparks
Andrew P Combs
James D Rodgers
Timothy C Burn
Jordan S Fridman

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit